2seventy Bio - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company Reports2seventy Bio

2seventy Bio(TSVT)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

b-cell lymphoma

,

inflammatory breast neoplasms

,

immunoglobulin light-chain amyloidosis

,

myeloproliferative disorders

,

primary myelofibrosis

,

promyelocytic leukemia acute

,

myelomonocytic leukemia chronic

,

myelomonocytic leukemia acute

,

myelomonocytic leukemia juvenile

,

,

systemic scleroderma

,

diffuse scleroderma

,

,

large b-cell lymphoma diffuse

,

,

myeloid leukemia acute

,

precursor cell lymphoblastic leukemia-lymphoma

,

non-hodgkin lymphoma

,

lymphoid leukemia

,

,

myeloid leukemia

,

myelodysplastic syndromes

,

multiple myeloma

,

plasma cell neoplasms

,

bcr-abl positive chronic myelogenous leukemia

,

,

,

b-cell chronic lymphocytic leukemia

,

triple negative breast neoplasms

,

refractory anemia with excess of blasts

,

renal insufficiency

,

hematologic diseases

,

blood protein disorders

,

neoplasms by histologic type

,

paraproteinemias

,

hodgkin disease

,

diabetes mellitus

,

type 1 diabetes mellitus

,

prolymphocytic leukemia t-cell

,

prolymphocytic leukemia

,

,

burkitt lymphoma

,

graft vs host disease

,

bronchiolitis obliterans syndrome

,

aplastic anemia

,

breast neoplasms

,

brain stem neoplasms

,

glycogen storage disease type ii

,

glycogen storage disease type iii

,

ovarian neoplasms

,

hematologic neoplasms

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use